These changes collectively contribute to a vicious cycle of “inflammation-insulin resistance-further obesity”: inflammatory factors promote lipid accumulation by inhibiting insulin signaling pathways, while simultaneously downregulating the anti-inflammatory adiponectin39,40, ultimately leading to metabolic dysfunction. The gene discussed is INS; the disease is Obesity.